Acquisition - DxTx Medical
DxTx medical device products help radiologists and urologists with enhanced imaging offering additional treatment options for the diagnosis and treatment of prostate cancer.
Endorectal coil, prostate image quality, prostate scans, prostate MRI, MRI images, prostate images, prostate cancer, prostate cancer treatment, prostate cancer diagnosis, increase prostate image quality, increase signal to noise, radiologists, urologists.
page-template,page-template-full_width,page-template-full_width-php,single,single-page,postid-16179,theme-bridge,bridge-core-3.0.9,qi-blocks-1.3,qodef-gutenberg--no-touch,woocommerce-no-js,qodef-qi--no-touch,qi-addons-for-elementor-1.7.6,qode-page-transition-enabled,ajax_fade,page_not_loaded,,columns-4,qode-child-theme-ver-1.0.0,qode-theme-ver-30.5.1,qode-theme-bridge,qode_header_in_grid,wpb-js-composer js-comp-ver-7.7.1,vc_responsive,elementor-default,elementor-kit-17954


DxTx Medical Acquires eCoil Line of Imaging Products from Bayer

PITTSBURGH, August 1, 2019 – DxTx Medical, a medical device manufacturer specializing in critical accessories that enable enhanced medical radiology applications, has acquired Bayer’s MR endorectal product line, which enables high-resolution imaging of the prostate, colorectal, cervix, and surrounding pelvis anatomy.

The transaction transfers the product line to DxTx Medical in a phased manner while DxTx Medical establishes its licensing and distribution infrastructure outside the U.S. With the first phase, effective August 1, DxTx Medical will manufacture and distribute for the U.S. market. Bayer will continue to support product sales to customers outside the U.S., marketed under the Medrad® eCoil brand, until August 31 (with the exception of the country of Italy, where the transition will take place September 30) at which time DxTx Medical will be responsible for product manufacturing and distribution globally. Customers outside the U.S. will receive more details from Bayer later this summer.

About the acquired MR Endorectal Coil

The acquired MR Endorectal coil provides a high signal-to-noise ratio (SNR), which enables the sensitivity needed for multi-parametric and spectroscopy imaging, on 1.5 and 3.0T MRI scanners. The small field of vision and high spatial resolution images with the endorectal coil can assist the radiologist by delivering improved sensitivity and specificity in diagnosis and aid in treatment planning.

While this product has been in the global healthcare market for more than 20 years, DxTx Medical plans to invest in upgrading interface device capabilities for newer platforms of MRI scanners.

“DxTx Medical is committed to providing medical professionals with technology that enhances their ability to provide the best treatment options for the patients they support,” Xueli Wang, President & CEO of DxTx Medical. “The eCoil MR Endorectal coil is well established in high resolution imaging and product support and warranty protection will continue as a mainstay for existing as well as new customers.”

About DxTx Medical

DxTx Medical (, located in O’Hara township outside of Pittsburgh, Pennsylvania, is a growing medical device company operated by industry veterans who are already well versed in medical devices such as the eCoil MR Endorectal coil.

“By managing this product line globally while at Bayer for many years, I have seen all the lives it has helped,” said Joseph Habovick, CCO of DxTx Medical. “In fact, most of our team has been involved with this product line over the years and we are eager to take its capabilities to the next level.”

DxTx Medical is well-positioned to expertly provide radiologists and urologists with specialized products that deliver enhanced endorectal imaging. This capability enables a more detailed diagnosis and treatment of prostate, colorectal and cervix applications. For more information call 1.833.777.3989 or email [email protected].

Interested in finding out more about our products?